Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 2.7.2025Zentiva, k.s. (ZNT-1)2452EDaruph 55 mg (tbl flm 60x55 mg (blis.OPA/Al/PVC/Al))2.7.2025R
 2.7.2025Zentiva, k.s. (ZNT-1)01198Dereflin 20 mg tvrdé gastrorezistentné kapsuly (cps end 98x20 mg (blis. PA/Al/PVC/Al))2.7.2025R
 1.7.2025Sanofi-Aventis Deutschland GmbH (SAV-D)36566LANTUS (sol inj 5x3 ml (skl. náplň v pere pre SoloStar))4.7.2025R
 1.7.2025CSL Behring GmbH (CSL)88205Alburex 20 (sol inf 1x50 ml/10 g (liek.skl.inj.))1.7.2025O
 1.7.2025CSL Behring GmbH (CSL)1309BHuman Albumin CSL Behring 200 g/l (sol inf 1x50 ml/9,6 g (liek.inj.skl.))1.7.2025R
 1.7.2025Viatris Healthcare Limited (VIM-1)6347CInfluvac Tetra (sus iru 10x0,5 ml (striek.inj.skl.napl. s ihlou))2.7.2025R
 1.7.2025Zentiva a.s. (ZNT-SK-2)27915Dilceren pro infusione (sol inf 1x50 ml/10 mg (fľ.inf.skl.hnedá))1.7.2025Z
 1.7.2025Viatris Healthcare Limited (VIM-1)9549CROZOR 10 mg/10 mg (tbl flm 30x10 mg/10 mg (blis.OPA/Al/PVC/Al))4.7.2025R
 1.7.2025Viatris Limited (VIM)35237Alfuzosin Viatris 10 mg (tbl plg 90x10 mg (blis.PVC/PVDC/Al))14.7.2025R
 1.7.2025TS Pharma s.r.o. (TPH-1)43044Tarka 180 mg/2 mg tablety (tbl flm 28x180 mg/2 mg (blis.PVC/PVDC/Al))14.7.2025R
 1.7.2025TS Pharma s.r.o. (TPH-1)02680MeniSerc 16 (tbl 60x16 mg (blis.PVC/PVDC/Al))1.7.2025O
 1.7.2025Aspen Pharma Trading Limited (ASE-1)97170Ovestin (crm vag 1x15 g (tuba Al+aplikátor))1.7.2025R
 1.7.2025Novartis Slovakia s.r.o. (NVL-2)92039Tegretol CR 200 (tbl mod 50x200 mg (blis.PVC/PE/PVDC/Al))1.7.2025O
 1.7.2025Viatris Limited (VIM)8980DTutecvi 50 mg (tbl 56x50 mg (blis.Al/Al))30.9.2025Z
 1.7.2025Viatris Limited (VIM)9262BRasagiline Viatris 1 mg tablety (tbl 28x1 mg (blis.PVC/PVDC/Al))31.8.2025Z

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To